nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Chloroquine—TNF—psoriatic arthritis	0.0215	1	CrCbGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.0106	0.0668	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.0105	0.0663	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.0103	0.0651	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.00993	0.0628	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL12B—psoriatic arthritis	0.00835	0.0528	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NOD2—psoriatic arthritis	0.00828	0.0524	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.00825	0.0522	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—NOD2—psoriatic arthritis	0.00813	0.0514	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—NOD2—psoriatic arthritis	0.00785	0.0496	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.00705	0.0446	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL12B—psoriatic arthritis	0.00652	0.0413	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—MEFV—psoriatic arthritis	0.00607	0.0384	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.00558	0.0353	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—MEFV—psoriatic arthritis	0.0048	0.0303	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MEFV—psoriatic arthritis	0.00354	0.0224	CbGpPWpGaD
Hydroxychloroquine—Skin discolouration—Methotrexate—psoriatic arthritis	0.00318	0.00388	CcSEcCtD
Hydroxychloroquine—Nausea—Auranofin—psoriatic arthritis	0.00315	0.00384	CcSEcCtD
Hydroxychloroquine—Affect lability—Triamcinolone—psoriatic arthritis	0.00311	0.00379	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—HLA-C—psoriatic arthritis	0.00311	0.0197	CbGpPWpGaD
Hydroxychloroquine—Affect lability—Methylprednisolone—psoriatic arthritis	0.00311	0.00379	CcSEcCtD
Hydroxychloroquine—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00308	0.00376	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Prednisolone—psoriatic arthritis	0.00303	0.0037	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00303	0.00369	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Betamethasone—psoriatic arthritis	0.00303	0.00369	CcSEcCtD
Hydroxychloroquine—Irritability—Methylprednisolone—psoriatic arthritis	0.00301	0.00367	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.003	0.00366	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.003	0.00366	CcSEcCtD
Hydroxychloroquine—Mood swings—Triamcinolone—psoriatic arthritis	0.003	0.00365	CcSEcCtD
Hydroxychloroquine—Mood swings—Methylprednisolone—psoriatic arthritis	0.00299	0.00364	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.00294	0.0186	CbGpPWpGaD
Hydroxychloroquine—Cardiac failure—Dexamethasone—psoriatic arthritis	0.00294	0.00358	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Betamethasone—psoriatic arthritis	0.00294	0.00358	CcSEcCtD
Hydroxychloroquine—Affect lability—Betamethasone—psoriatic arthritis	0.00282	0.00344	CcSEcCtD
Hydroxychloroquine—Affect lability—Dexamethasone—psoriatic arthritis	0.00282	0.00344	CcSEcCtD
Hydroxychloroquine—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.0028	0.00342	CcSEcCtD
Hydroxychloroquine—Psychotic disorder—Betamethasone—psoriatic arthritis	0.0028	0.00342	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—MEFV—psoriatic arthritis	0.00279	0.0177	CbGpPWpGaD
Hydroxychloroquine—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00279	0.0034	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00278	0.00339	CcSEcCtD
Hydroxychloroquine—Irritability—Betamethasone—psoriatic arthritis	0.00274	0.00334	CcSEcCtD
Hydroxychloroquine—Irritability—Dexamethasone—psoriatic arthritis	0.00274	0.00334	CcSEcCtD
Hydroxychloroquine—Mood swings—Dexamethasone—psoriatic arthritis	0.00272	0.00331	CcSEcCtD
Hydroxychloroquine—Mood swings—Betamethasone—psoriatic arthritis	0.00272	0.00331	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.0027	0.00329	CcSEcCtD
Hydroxychloroquine—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00268	0.00327	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Prednisone—psoriatic arthritis	0.00256	0.00312	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00253	0.00308	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Betamethasone—psoriatic arthritis	0.00253	0.00308	CcSEcCtD
Hydroxychloroquine—Affect lability—Prednisone—psoriatic arthritis	0.00246	0.003	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-C—psoriatic arthritis	0.00246	0.0155	CbGpPWpGaD
Hydroxychloroquine—Psychotic disorder—Prednisone—psoriatic arthritis	0.00244	0.00297	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Prednisolone—psoriatic arthritis	0.00239	0.00291	CcSEcCtD
Hydroxychloroquine—Irritability—Prednisone—psoriatic arthritis	0.00238	0.00291	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Prednisolone—psoriatic arthritis	0.00238	0.0029	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Methotrexate—psoriatic arthritis	0.00238	0.0029	CcSEcCtD
Hydroxychloroquine—Mood swings—Prednisone—psoriatic arthritis	0.00237	0.00289	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.00232	0.0147	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	0.0023	0.0145	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Prednisolone—psoriatic arthritis	0.00229	0.00279	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—NOD2—psoriatic arthritis	0.00229	0.0145	CbGpPWpGaD
Hydroxychloroquine—Weight decreased—Betamethasone—psoriatic arthritis	0.00224	0.00273	CcSEcCtD
Hydroxychloroquine—Weight decreased—Dexamethasone—psoriatic arthritis	0.00224	0.00273	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.00221	0.0027	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Prednisone—psoriatic arthritis	0.0022	0.00269	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Methotrexate—psoriatic arthritis	0.0022	0.00269	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Triamcinolone—psoriatic arthritis	0.0022	0.00268	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00219	0.00267	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00219	0.00267	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00218	0.00266	CcSEcCtD
Hydroxychloroquine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.0021	0.00256	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00204	0.00249	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00199	0.00243	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Betamethasone—psoriatic arthritis	0.00199	0.00243	CcSEcCtD
Hydroxychloroquine—Irritability—Methotrexate—psoriatic arthritis	0.00199	0.00243	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Betamethasone—psoriatic arthritis	0.00198	0.00242	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00198	0.00242	CcSEcCtD
Hydroxychloroquine—Mood swings—Methotrexate—psoriatic arthritis	0.00198	0.00241	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—REL—psoriatic arthritis	0.00197	0.0124	CbGpPWpGaD
Hydroxychloroquine—Ataxia—Methotrexate—psoriatic arthritis	0.00196	0.00239	CcSEcCtD
Hydroxychloroquine—Weight decreased—Prednisone—psoriatic arthritis	0.00195	0.00238	CcSEcCtD
Hydroxychloroquine—Vision blurred—Prednisolone—psoriatic arthritis	0.00195	0.00238	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00193	0.00235	CcSEcCtD
Hydroxychloroquine—Depression—Prednisone—psoriatic arthritis	0.00192	0.00234	CcSEcCtD
Hydroxychloroquine—Visual impairment—Dexamethasone—psoriatic arthritis	0.00191	0.00233	CcSEcCtD
Hydroxychloroquine—Visual impairment—Betamethasone—psoriatic arthritis	0.00191	0.00233	CcSEcCtD
Hydroxychloroquine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00191	0.00233	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.0019	0.00232	CcSEcCtD
Hydroxychloroquine—Angioedema—Prednisolone—psoriatic arthritis	0.00189	0.00231	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00188	0.00229	CcSEcCtD
Hydroxychloroquine—Vertigo—Prednisolone—psoriatic arthritis	0.00186	0.00227	CcSEcCtD
Hydroxychloroquine—Eye disorder—Betamethasone—psoriatic arthritis	0.00185	0.00226	CcSEcCtD
Hydroxychloroquine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00185	0.00226	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—HLA-B—psoriatic arthritis	0.00184	0.0116	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00182	0.00222	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	0.00181	0.0115	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HLA-C—psoriatic arthritis	0.00181	0.0114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NOD2—psoriatic arthritis	0.00181	0.0114	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Prednisolone—psoriatic arthritis	0.00179	0.00219	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Methotrexate—psoriatic arthritis	0.00179	0.00218	CcSEcCtD
Hydroxychloroquine—Alopecia—Betamethasone—psoriatic arthritis	0.00175	0.00214	CcSEcCtD
Hydroxychloroquine—Alopecia—Dexamethasone—psoriatic arthritis	0.00175	0.00214	CcSEcCtD
Hydroxychloroquine—Angioedema—Triamcinolone—psoriatic arthritis	0.00174	0.00212	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Prednisone—psoriatic arthritis	0.00174	0.00212	CcSEcCtD
Hydroxychloroquine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00174	0.00212	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Prednisone—psoriatic arthritis	0.00173	0.00211	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Methotrexate—psoriatic arthritis	0.00171	0.00209	CcSEcCtD
Hydroxychloroquine—Vertigo—Triamcinolone—psoriatic arthritis	0.00171	0.00209	CcSEcCtD
Hydroxychloroquine—Vertigo—Methylprednisolone—psoriatic arthritis	0.00171	0.00208	CcSEcCtD
Hydroxychloroquine—Oedema—Prednisolone—psoriatic arthritis	0.00169	0.00206	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00167	0.00204	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00167	0.00204	CcSEcCtD
Hydroxychloroquine—Convulsion—Triamcinolone—psoriatic arthritis	0.00165	0.00201	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00165	0.00201	CcSEcCtD
Hydroxychloroquine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00165	0.00201	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CRP—psoriatic arthritis	0.00162	0.0103	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Prednisone—psoriatic arthritis	0.00162	0.00197	CcSEcCtD
Hydroxychloroquine—Drowsiness—Methotrexate—psoriatic arthritis	0.00161	0.00196	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00161	0.00196	CcSEcCtD
Hydroxychloroquine—Depression—Methotrexate—psoriatic arthritis	0.0016	0.00196	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.0016	0.00194	CcSEcCtD
Hydroxychloroquine—Angioedema—Dexamethasone—psoriatic arthritis	0.00158	0.00192	CcSEcCtD
Hydroxychloroquine—Angioedema—Betamethasone—psoriatic arthritis	0.00158	0.00192	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—REL—psoriatic arthritis	0.00155	0.00983	CbGpPWpGaD
Hydroxychloroquine—Oedema—Triamcinolone—psoriatic arthritis	0.00155	0.00189	CcSEcCtD
Hydroxychloroquine—Vertigo—Betamethasone—psoriatic arthritis	0.00155	0.00189	CcSEcCtD
Hydroxychloroquine—Vertigo—Dexamethasone—psoriatic arthritis	0.00155	0.00189	CcSEcCtD
Hydroxychloroquine—Alopecia—Prednisone—psoriatic arthritis	0.00153	0.00186	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00152	0.00185	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00152	0.00185	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00152	0.00185	CcSEcCtD
Hydroxychloroquine—Mental disorder—Prednisone—psoriatic arthritis	0.00151	0.00185	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00151	0.00184	CcSEcCtD
Hydroxychloroquine—Malnutrition—Prednisone—psoriatic arthritis	0.0015	0.00183	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.0015	0.00183	CcSEcCtD
Hydroxychloroquine—Convulsion—Betamethasone—psoriatic arthritis	0.0015	0.00182	CcSEcCtD
Hydroxychloroquine—Convulsion—Dexamethasone—psoriatic arthritis	0.0015	0.00182	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—HLA-B—psoriatic arthritis	0.00145	0.00919	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Methotrexate—psoriatic arthritis	0.00145	0.00177	CcSEcCtD
Hydroxychloroquine—Pain—Prednisolone—psoriatic arthritis	0.00145	0.00176	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Methotrexate—psoriatic arthritis	0.00144	0.00176	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-C—psoriatic arthritis	0.00143	0.00905	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Prednisone—psoriatic arthritis	0.00142	0.00173	CcSEcCtD
Hydroxychloroquine—Oedema—Betamethasone—psoriatic arthritis	0.00141	0.00172	CcSEcCtD
Hydroxychloroquine—Oedema—Dexamethasone—psoriatic arthritis	0.00141	0.00172	CcSEcCtD
Hydroxychloroquine—Visual impairment—Methotrexate—psoriatic arthritis	0.00139	0.0017	CcSEcCtD
Hydroxychloroquine—Anaemia—Prednisone—psoriatic arthritis	0.00139	0.0017	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00138	0.00169	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00138	0.00169	CcSEcCtD
Hydroxychloroquine—Agitation—Prednisone—psoriatic arthritis	0.00138	0.00169	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00138	0.00168	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00138	0.00168	CcSEcCtD
Hydroxychloroquine—Angioedema—Prednisone—psoriatic arthritis	0.00137	0.00168	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00137	0.00166	CcSEcCtD
Hydroxychloroquine—Vertigo—Prednisone—psoriatic arthritis	0.00135	0.00165	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methotrexate—psoriatic arthritis	0.00135	0.00165	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—psoriatic arthritis	0.00135	0.00164	CcSEcCtD
Hydroxychloroquine—Anorexia—Dexamethasone—psoriatic arthritis	0.00134	0.00164	CcSEcCtD
Hydroxychloroquine—Anorexia—Betamethasone—psoriatic arthritis	0.00134	0.00164	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisolone—psoriatic arthritis	0.00134	0.00164	CcSEcCtD
Hydroxychloroquine—Fatigue—Triamcinolone—psoriatic arthritis	0.00134	0.00163	CcSEcCtD
Hydroxychloroquine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00134	0.00163	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—NOD2—psoriatic arthritis	0.00133	0.00842	CbGpPWpGaD
Hydroxychloroquine—Pain—Triamcinolone—psoriatic arthritis	0.00133	0.00162	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00132	0.00161	CcSEcCtD
Hydroxychloroquine—Convulsion—Prednisone—psoriatic arthritis	0.0013	0.00159	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CRP—psoriatic arthritis	0.00128	0.00812	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Methotrexate—psoriatic arthritis	0.00128	0.00156	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00127	0.00155	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00127	0.00155	CcSEcCtD
Hydroxychloroquine—Mental disorder—Methotrexate—psoriatic arthritis	0.00127	0.00154	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methotrexate—psoriatic arthritis	0.00126	0.00153	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00125	0.00152	CcSEcCtD
Hydroxychloroquine—Urticaria—Triamcinolone—psoriatic arthritis	0.00123	0.0015	CcSEcCtD
Hydroxychloroquine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00123	0.0015	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00123	0.0015	CcSEcCtD
Hydroxychloroquine—Oedema—Prednisone—psoriatic arthritis	0.00123	0.0015	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00123	0.00149	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00123	0.00149	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00123	0.00149	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00122	0.00148	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00122	0.00148	CcSEcCtD
Hydroxychloroquine—Fatigue—Dexamethasone—psoriatic arthritis	0.00122	0.00148	CcSEcCtD
Hydroxychloroquine—Fatigue—Betamethasone—psoriatic arthritis	0.00122	0.00148	CcSEcCtD
Hydroxychloroquine—Pain—Dexamethasone—psoriatic arthritis	0.00121	0.00147	CcSEcCtD
Hydroxychloroquine—Pain—Betamethasone—psoriatic arthritis	0.00121	0.00147	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Prednisone—psoriatic arthritis	0.0012	0.00147	CcSEcCtD
Hydroxychloroquine—Skin disorder—Prednisone—psoriatic arthritis	0.00119	0.00145	CcSEcCtD
Hydroxychloroquine—Vision blurred—Methotrexate—psoriatic arthritis	0.00119	0.00144	CcSEcCtD
Hydroxychloroquine—Anorexia—Prednisone—psoriatic arthritis	0.00117	0.00143	CcSEcCtD
Hydroxychloroquine—Anaemia—Methotrexate—psoriatic arthritis	0.00116	0.00142	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00115	0.00141	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00115	0.00141	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00115	0.0014	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00114	0.00139	CcSEcCtD
Hydroxychloroquine—Vertigo—Methotrexate—psoriatic arthritis	0.00113	0.00138	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methotrexate—psoriatic arthritis	0.00113	0.00137	CcSEcCtD
Hydroxychloroquine—Urticaria—Betamethasone—psoriatic arthritis	0.00112	0.00137	CcSEcCtD
Hydroxychloroquine—Urticaria—Dexamethasone—psoriatic arthritis	0.00112	0.00137	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisolone—psoriatic arthritis	0.00112	0.00136	CcSEcCtD
Hydroxychloroquine—Asthenia—Triamcinolone—psoriatic arthritis	0.00112	0.00136	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00111	0.00136	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Betamethasone—psoriatic arthritis	0.00111	0.00136	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00111	0.00136	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00111	0.00136	CcSEcCtD
Hydroxychloroquine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00111	0.00136	CcSEcCtD
Hydroxychloroquine—Pruritus—Triamcinolone—psoriatic arthritis	0.0011	0.00134	CcSEcCtD
Hydroxychloroquine—Pruritus—Methylprednisolone—psoriatic arthritis	0.0011	0.00134	CcSEcCtD
Hydroxychloroquine—Convulsion—Methotrexate—psoriatic arthritis	0.00109	0.00133	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HLA-B—psoriatic arthritis	0.00107	0.00677	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Prednisone—psoriatic arthritis	0.00107	0.0013	CcSEcCtD
Hydroxychloroquine—Rash—Prednisolone—psoriatic arthritis	0.00107	0.0013	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisolone—psoriatic arthritis	0.00106	0.0013	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00106	0.0013	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00106	0.00129	CcSEcCtD
Hydroxychloroquine—Fatigue—Prednisone—psoriatic arthritis	0.00106	0.00129	CcSEcCtD
Hydroxychloroquine—Headache—Prednisolone—psoriatic arthritis	0.00106	0.00129	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NOD2—psoriatic arthritis	0.00105	0.00665	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Triamcinolone—psoriatic arthritis	0.00103	0.00125	CcSEcCtD
Hydroxychloroquine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00103	0.00125	CcSEcCtD
Hydroxychloroquine—Asthenia—Dexamethasone—psoriatic arthritis	0.00101	0.00123	CcSEcCtD
Hydroxychloroquine—Asthenia—Betamethasone—psoriatic arthritis	0.00101	0.00123	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00101	0.00123	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.001	0.00122	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.001	0.00122	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisolone—psoriatic arthritis	0.001	0.00122	CcSEcCtD
Hydroxychloroquine—Pruritus—Betamethasone—psoriatic arthritis	0.000998	0.00122	CcSEcCtD
Hydroxychloroquine—Pruritus—Dexamethasone—psoriatic arthritis	0.000998	0.00122	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methotrexate—psoriatic arthritis	0.000997	0.00122	CcSEcCtD
Hydroxychloroquine—Vomiting—Triamcinolone—psoriatic arthritis	0.000988	0.0012	CcSEcCtD
Hydroxychloroquine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000986	0.0012	CcSEcCtD
Hydroxychloroquine—Rash—Triamcinolone—psoriatic arthritis	0.00098	0.00119	CcSEcCtD
Hydroxychloroquine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000979	0.00119	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—psoriatic arthritis	0.000978	0.00119	CcSEcCtD
Hydroxychloroquine—Rash—Methylprednisolone—psoriatic arthritis	0.000978	0.00119	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000977	0.00119	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisone—psoriatic arthritis	0.000976	0.00119	CcSEcCtD
Hydroxychloroquine—Headache—Triamcinolone—psoriatic arthritis	0.000974	0.00119	CcSEcCtD
Hydroxychloroquine—Headache—Methylprednisolone—psoriatic arthritis	0.000971	0.00118	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Prednisone—psoriatic arthritis	0.000971	0.00118	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Prednisone—psoriatic arthritis	0.000971	0.00118	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000965	0.00118	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000965	0.00118	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CRP—psoriatic arthritis	0.000946	0.00598	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Betamethasone—psoriatic arthritis	0.000933	0.00114	CcSEcCtD
Hydroxychloroquine—Dizziness—Dexamethasone—psoriatic arthritis	0.000933	0.00114	CcSEcCtD
Hydroxychloroquine—Nausea—Triamcinolone—psoriatic arthritis	0.000923	0.00113	CcSEcCtD
Hydroxychloroquine—Nausea—Methylprednisolone—psoriatic arthritis	0.000921	0.00112	CcSEcCtD
Hydroxychloroquine—Somnolence—Methotrexate—psoriatic arthritis	0.000912	0.00111	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HLA-DRB1—psoriatic arthritis	0.000906	0.00573	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000905	0.0011	CcSEcCtD
Hydroxychloroquine—Vomiting—Betamethasone—psoriatic arthritis	0.000897	0.00109	CcSEcCtD
Hydroxychloroquine—Vomiting—Dexamethasone—psoriatic arthritis	0.000897	0.00109	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000892	0.00109	CcSEcCtD
Hydroxychloroquine—Rash—Dexamethasone—psoriatic arthritis	0.000889	0.00108	CcSEcCtD
Hydroxychloroquine—Rash—Betamethasone—psoriatic arthritis	0.000889	0.00108	CcSEcCtD
Hydroxychloroquine—Dermatitis—Betamethasone—psoriatic arthritis	0.000888	0.00108	CcSEcCtD
Hydroxychloroquine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000888	0.00108	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000886	0.00108	CcSEcCtD
Hydroxychloroquine—Fatigue—Methotrexate—psoriatic arthritis	0.000885	0.00108	CcSEcCtD
Hydroxychloroquine—Headache—Dexamethasone—psoriatic arthritis	0.000883	0.00108	CcSEcCtD
Hydroxychloroquine—Headache—Betamethasone—psoriatic arthritis	0.000883	0.00108	CcSEcCtD
Hydroxychloroquine—Asthenia—Prednisone—psoriatic arthritis	0.000881	0.00107	CcSEcCtD
Hydroxychloroquine—Pain—Methotrexate—psoriatic arthritis	0.000878	0.00107	CcSEcCtD
Hydroxychloroquine—Pruritus—Prednisone—psoriatic arthritis	0.000869	0.00106	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-B—psoriatic arthritis	0.000846	0.00535	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Prednisone—psoriatic arthritis	0.00084	0.00102	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000839	0.00102	CcSEcCtD
Hydroxychloroquine—Nausea—Betamethasone—psoriatic arthritis	0.000838	0.00102	CcSEcCtD
Hydroxychloroquine—Nausea—Dexamethasone—psoriatic arthritis	0.000838	0.00102	CcSEcCtD
Hydroxychloroquine—Urticaria—Methotrexate—psoriatic arthritis	0.000815	0.000994	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisone—psoriatic arthritis	0.000812	0.00099	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000811	0.000989	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000811	0.000989	CcSEcCtD
Hydroxychloroquine—Vomiting—Prednisone—psoriatic arthritis	0.000781	0.000952	CcSEcCtD
Hydroxychloroquine—Rash—Prednisone—psoriatic arthritis	0.000774	0.000944	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisone—psoriatic arthritis	0.000774	0.000943	CcSEcCtD
Hydroxychloroquine—Headache—Prednisone—psoriatic arthritis	0.000769	0.000938	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000756	0.000922	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CRP—psoriatic arthritis	0.000748	0.00473	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Methotrexate—psoriatic arthritis	0.000736	0.000898	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisone—psoriatic arthritis	0.000729	0.000889	CcSEcCtD
Hydroxychloroquine—Pruritus—Methotrexate—psoriatic arthritis	0.000726	0.000885	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—HLA-DRB1—psoriatic arthritis	0.000716	0.00453	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000702	0.000856	CcSEcCtD
Hydroxychloroquine—Dizziness—Methotrexate—psoriatic arthritis	0.000679	0.000827	CcSEcCtD
Hydroxychloroquine—Vomiting—Methotrexate—psoriatic arthritis	0.000653	0.000795	CcSEcCtD
Hydroxychloroquine—Rash—Methotrexate—psoriatic arthritis	0.000647	0.000789	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—psoriatic arthritis	0.000647	0.000788	CcSEcCtD
Hydroxychloroquine—Headache—Methotrexate—psoriatic arthritis	0.000643	0.000784	CcSEcCtD
Hydroxychloroquine—Nausea—Methotrexate—psoriatic arthritis	0.00061	0.000743	CcSEcCtD
